Who owns the GEXREV trademark?

The GEXREV trademark is owned by Sangamo Therapeutics, Inc..

What class is the GEXREV trademark registered in?

The GEXREV trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for GEXREV?

The USPTO serial number for GEXREV is 99061507.

What is the registration number for GEXREV?

GEXREV is registered under USPTO registration number 0.

Sealvo

Home Search: GEXREVGEXREV #99061507

Back

Updated Oct 30, 2026·10 searches this week

View on USPTO TSDR Find similar marks

GEX

USPTO Trademark Record

PENDING

GEXREV

SN 99061507·Reg 0·Filed Feb 28, 2025

Owner Sangamo Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

GEXREV (Serial No. 99061507), Registration No. 0, is a pending US trademark filed on Feb 28, 2025 by Sangamo Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Opposition window open — 20 days left to challengeURGENT

Mark Intelligence

GEXREV (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 28, 2025

SERIAL

99061507

REG#

Filing Information

StatusPENDING

Filing DateFeb 28, 2025

Serial Number99061507

Registration No.0

Status DateOct 20, 2026

Published for OppositionOct 20, 2026

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

28 events

PUBLISHED FOR OPPOSITION

Oct 20, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 20, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 14, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXPARTE APPEAL TERMINATED

Sep 22, 2026

EXPARTE APPEAL TERMINATED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 21, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

EXPARTE APPEAL RECEIVED AT TTAB

Aug 23, 2026

EXPARTE APPEAL RECEIVED AT TTAB

JURISDICTION RESTORED TO EXAMINING ATTORNEY

Aug 23, 2026

JURISDICTION RESTORED TO EXAMINING ATTORNEY

EX PARTE APPEAL-INSTITUTED

Aug 23, 2026

EX PARTE APPEAL-INSTITUTED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 22, 2026

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 22, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 22, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 19, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 19, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

FINAL REFUSAL WRITTEN

Feb 23, 2026

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Feb 23, 2026

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Feb 23, 2026

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 04, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 04, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 04, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Oct 29, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Oct 29, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

ASSIGNED TO EXAMINER

Aug 04, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Aug 04, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 04, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 04, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Feb 28, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 28, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 28, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by Sangamo Therapeutics, Inc.

Additional USPTO filings from the same owner.

SAN

SANGAMO THERAPEUTICS

90420060

Sangamo Therapeutics, Inc.

REGISTERED

SAN

SANGAMO THERAPEUTICS

90420110

Sangamo Therapeutics, Inc.

REGISTERED

SIF

SIFTER

97301380

Sangamo Therapeutics, Inc.

ABANDONED

SAN

SANGAMO THERAPEUTICS

87252702

SANGAMO THERAPEUTICS, INC.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

GEX

GEXREV

98208297

Pfizer Inc.

ABANDONED

Other Marks by R. GWEN PETERSON

Additional USPTO filings handled by the same attorney of record.

R+F

87448372

REGISTERED

PAR

PARADISUS DEI

78703159

REGISTERED

GOL

GOLDEN HOUR

99358168

REGISTERED

TWS

TW SHADOW

98605379

REGISTERED

GEXREV

Run a conflict check

Other Marks by Sangamo Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by R. GWEN PETERSON

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company